Published Articles in Refereed Journals:

2001

• Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, Williams B, Pajak TF, Goepfert H, Hong WK. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiology, Biomarkers and Prevention, 10(8):823-829, 2001.

• Khuri FR, Lee JS, Lippman SM, Lee JJ, Kalapurakal S, Yu R, Ro JY, Morice RC, Hong WK, Hittelman WN. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers. Cancer Epidemiology, Biomarkers and Prevention, 10(4):311-318, 2001.

• Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, Feng L, Hong WK, Xu XC. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clinical Cancer Research, 7(4):861-867, 2001.

• Lee JJ, Lieberman R, Sloan JA, Piantadosi S, Lippman SM. Design considerations for efficient prostate cancer chemoprevention trials. Urology 57 (4 Suppl 1):205-212, 2001.

• Lee JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, Morice RC, Walsh G, Ro JY, Broxson A, Hong WK, Hittelman WN. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. Journal of the National Cancer Institute, 93(14):1081-1088, 2001.

• Lee JJ,Tseng C. Uniform power method for sample size calculation in historical control studies with binary response. Controlled Clinical Trials, 22(4):390-400, 2001.

• Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM. Executive summary of the National Cancer Institute workshop: highlights and recommendations. Urology, 57 (4 Suppl 1):4-27, 2001.

• Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK. Randomized phase III intergroup trial of isoretinoin to prevent second primary tumors in stage I non-small cell lung cancer. Journal of the National Cancer Institute, 93(8):605-618, 2001.

• Shin DM, Charuruks N, Lippman SM, Lee JJ, Ro JY, Hong WK, Hittelman WN. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis. Cancer Epidemiology, Biomarkers and Prevention, 10(6):603-609, 2001.

• Soria JC, Moon C, Wang L, Hittelman WN, Jang SL, Sun SY, Lee JJ, Liu D, Kurie JM, Morice RC, Lee JS, Hong WK, Mao L. Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. Journal of the National Cancer Institute, 93(16):1257-1263, 2001.

2000

• Herbst RS, Yano S, Kuriyasu H, Khuri F, Bucana CP, Guo F, Liu D, Kemp B, Lee JJ, Hong WK, Fidler IJ. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clinical Cancer Research, 6:790-797, 2000.

• Lee JJ, Hess KR, Dubin JA. Extensions and applications of event charts. The American Statistician, 54:63-70, 2000.

• Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Weill D, Wiat J, Lawrence DD, Kemp BL, Fossells F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Richli WR, Shin DM, Walsh GL, et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. Journal of Clinical Oncology, 18: 609-22, 2000.

• Shin DM, Mao L, Papadimitrakopoulou V, Clayman G, El-Naggar A, Shin HJC, Lee JJ, Lee JS, Gillenwater A, Lippman SM, Hittelman WN, Hong WK. Biochemopreventive therapy of patients with premalignant lesions of the head and neck and p53 gene expression. Journal of the National Cancer Institute, 92:69-73, 2000.

• Zhou X, Kemp, BL Khuri FR, Liu D, Lee JJ, Wu W, Hong WK, Mao L. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clinical Cancer Research, 6:559-565, 2000.

1999

• Thall PF, Lee JJ, Tseng C-H, Estey E. Accrual strategies for phase I trials with delayed patient outcome. Statistics in Medicine, 18:1155-1169, 1999.

• Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng C-H, Lee JJ, Balch CM, Reintgen DS, Ross MI. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. Journal of Clinical Oncology, 17:976-983, 1999.

• Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar A, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KMW, Putnam JB, et al. Adenovirus-mediated p53 gene transfer in advanced non-small lung cancer. Journal of the National Cancer Institute, 91:76-3771, 1999.

• Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Hong WK, Lotan R. Nuclear retinoid receptor beta in bronchial epithelium of smokers before and during chemoprevention. Journal of the National Cancer Institute, 91:1317-1321, 1999.

• Gershenson DM, Morris M, Burke TW, Levenback C, Wolf J, Lee JJ, Thall PF, Atkinson EN, Silva EG, Wharton JT. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer, 86:2291-2300, 1999.

• Ellerhorst J, Troncoso P, Xu X-C, Lee JJ, Lotan R. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Urology Research 27:362-367, 1999.

1998

• Spitz MR, Lippman SM, Jiang H, Lee JJ, Khuri F, Hsu TC, Trizna Z, Schantz SP, Benner S, Hong WK. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. Journal of the National Cancer Institute, 90:243-245, 1998.

• Shin DM, Glisson BS, Khuri F, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Hong WK, Lippman SM. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. Journal of Clinical Oncology, 16:1325-1330, 1998.

• Mitchell MF, Tortolero-Luna G, Lee JJ, Hittelman WK, Lotan R, Wharton JT, Hong WK, Nishioka K. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Clinical Cancer Research, 4:303-310, 1998.

• Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CP, Fang B, Lee JJ, Roth JA. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression ad inhibits angiogenesis in human colon cancer. Cancer Research, 58:2288-2292, 1998.

• Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR. Deletion in poly (ADP-ribose) polymerase pseudogene and lung cancer risk. Carcinogenesis, 19:93-98, 1998.

• Buzaid AC, Ali-Osman F, Akande N, Grimm EA, Lee JJ, Bedikian A, Eaton O, Papadopoulos N, Plager C, Legha SS, Benjamin R. DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma. Melanoma Research, 8:145-148, 1998.

• Anderson CM, Buzaid AC, Sussman,J, Lee JJ, Ali-Osman F, Braunschweiger G, Plager C, Bedekian A, Papadopoulos N, Eton O, Legha SS, Grimm EA. Nitric oxide and neopterin levels and clinic response in stage III melanoma patients receiving concurrent biochemotherapy. Melanoma Research, 8:149-155, 1998.

• Zhou J, Mulshin JL, Ro JR, Avis I, Yu R, Lee JJ, Morice R, Lippman SM, Lee JS. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clinical Cancer Research, 4:1631-1640, 1998.

• Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C-H, Lee JJ, Balch CM, Ross MI. Pattern of recurrence following a negative sentinel lymph node biopsy in 243 patients with Stage I or II melanoma. Journal of Clinical Oncology, 16:2253-2260, 1998.

• Gershenwald JE, Tseng C-H, Thompson W, Mansfield PF, Lee JE, Bouvet M, Lee JJ, Ross MI. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery, 124:203-210, 1998.

• Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, Winn RJ, Fu KK, Cooper J, Spitz MR. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. Journal of the National Cancer Institute, 90:1393-1399, 1998.

• Lippman SM, Lee JJ, Sabichi AL. Cancer chemoprevention: Progress and promise. Journal of the National Cancer Institute, 90:1514-1528, 1998.

• Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, Fan Y, Zhou X, Clayman G, Lee JJ, Lee JS, Hittelman WN, Lippman SM, Hong WK. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. Journal of the National Cancer Institute, 90:1545-1551, 1998.

• Staniswalis JG, Lee JJ. Nonparametric regression analyses of longitudinal data. Journal of the American Statistical Association, 93:1403-1418, 1998.

• Buzaid AC, Colome M, Bedikian A, Eton O, Legha SS, Papadopoulos N, Plager C, Ross M, Lee JE, Mansfield P, Rice J, Ring S, Lee JJ, Strom E, Benjamin R. Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases. Melanoma Research, 8:549-556,1998.

Earlier publications

• Shin HJC, Kalapurakal SK, Lee JJ, Ro JY, Hong WK, Lee JS. Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating. Modern Pathology, 10:224-230, 1997.

• Xu X-C, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK, Lotan R. Suppression of nuclear retinoic acid receptor ß in non-small cell lung cancer in vivo: implications for lung cancer development. Journal of National Cancer Institute, 89:624-629, 1997.

• Papadimitrakopoulou VA, Hong WK, Lee JS, Martin JW, Lee JJ, Batsakis JG, Lippman SM. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. Journal of the National Cancer Institute, 89:257-258, 1997.

• Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp B, Khuri F, Walsh GL, Hittelman WN, Hong WK. Clonal genetic alterations in the lungs of current and former smokers. Journal of National Cancer Institute, 89:857-862, 1997.

• Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, Fritsche HA, Lippman SM. Phase I trial of alpha tocopherol effects on 13-cis-retinoic acid toxicity. Annals of Oncology, 8:85-89, 1997.

• Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM. Cisplatin, fluorouracil, and l-leucovorin induction chemotherapy for locally advanced head and neck cancer: The M.D. Anderson Cancer Center Experience. The Cancer Journal, 8:92-99, 1997.

• Jung FA, Buzaid AC, Ross MI, Woods KV, Lee JJ, Albitar M, Grimm EA. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. Journal of Clinical Oncology, 15:2826-2831, 1997.

• Spitz MR, McPherson S, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lippman SM, Khuri FR, Steffen-Batey L, Chamberlain RM, Schantz SP, Hong WK. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiology, Biomarkers and Prevention, 6:687-692, 1997.

• Lee JJ, Serachitopol DM, Brown BW. Likelihood weighted confidence intervals for the difference of two binomial proportions. Biometrical Journal, 39:387-407, 1997.

• Shin DM, Xu XC, Lippman SM, Lee JJ, Lee JS, Batsakis JG, Ro JY, Martin JW, Hittelman WN, Lotan R, Hong WK. Accumulation of p53 protein and retinoic acid receptor-ß in retinoid chemoprevention. Clinical Cancer Research, 3:875-880, 1997.

• Lee JJ, Tu ZN. A versatile one-dimensional distribution plot: the BLiP plot. The American Statistician, 51:353-358, 1997.

• Konishi H, Steinbach G, Terry NHA, Fujita K, Lee JJ, Spaulding DC, Dubin JA, Hittelman WN. S phase determination in intact colonic crypts by histone H3 mRNA in situ hybridization and confocal microscopy. Cancer Epidemiology, Biomarkers and Prevention, 6:531-536, 1997.

• Xu X, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. Progressive decrease in nuclear retinoic acid receptor-beta mRNA level during breast carcinogenesis. Cancer Research, 57:4992-4996, 1997.

• El-Naggar AK, Lai S, Clayman G, Lee JJ, Luna MA, Goepfert H, Batsakis JG. Methylation: a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. American Journal of Pathology, 151:1767-1774, 1997.

• Mitchell MF, Tortolero-Luna G, Lee JJ, Hittelman WK, Lotan R, Wharton JT, Hong WK, Nishioka K. Polyamine measurements in the uterine cervix. Journal of Cell Biochemistry, Supplement 28-29:125-132, 1997.

• Smith TL, Lee JJ, Kantarjian HM, Legha SS, Raber MN. Design and results of phase I cancer clinical trials: 3-year experience at M.D. Anderson Cancer Center. Journal of Clinical Oncology 14:287-295, 1996.

• Konishi H, Steinbach G, Terry NHA, Lee JJ, Dubin J, Glober G, Fujita K, Spaulding D, Cass L, Hittelman WN. Histone H3 Messenger RNA in situ hybridization correlates with in vivo Bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium. Cancer Research 56:434-437, 1996.

• Lee JJ, Trizna Z, Hsu TC, Spitz MR, Hong, WK. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiology, Biomarkers and Prevention, 5:191-197,1996.

• Perez-Soler R, Fossella FV, Glisson BS, Lee JS, Murphy WK, Shin DM, Kemp BL, Lee JJ, Kane J, Robinson RA, Lippman SM, Kurie JM, Huber MH, Raber M, Hong WK. Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy. Journal of Clinical Oncology, 14: 503-513, 1996.

• Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJC, Ro JY, Goepfert H, Hong WK, Hittelman WN. p53 Expression: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. Journal of National Cancer Institute, 88: 519-529, 1996.

• Steinbach G, Lupton J, Reddy BS, Lee JJ, Kral JG, Holt PR. Calcium carbonate treatment of diarrhoea in intestinal bypass patients. European Journal of Gastroenterology & Hepatology, 8:559-562, 1996.

• Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han C-I, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Medicine, 2:985-991, 1996.

• Sim SJ, Glassman AB, Ro JY, Lee JJ, Logothetis CJ, Liu FJ. Serum calcitonin in small cell carcinoma of the prostate. Annals of Clinical and Laboratory Science, 26:487-495, 1996.

• Kurie JM, Shin HJC, Lee JS, Morice RC, Ro JY, Lippman SM, Hittelman WN, Yu R, Lee JJ, Hong WK. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clinical Cancer Research, 2:1787-1793, 1996.

• Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL. bcl -2 and p53 expression in resectable pancreatic adenocarcinomas: Association with clinical outcome. Clinical Cancer Research, 2:2015-2022, 1996.

• Ehteshami M, Ro JY, Shin HJC, Lee JJ, Ordonez NG, Ayala AG. p53 expression and tumor proliferative activity in testicular germ cell tumors: An immunohistochemical and clinicopathologic study. International Journal of Oncology, 9:787-793, 1996.

• Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Research 55: 16-19, 1995.

• Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B.  bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Research 55:237-241, 1995.

• Clayman GL, Chamberlain RM, Lee JJ, Lippman SM, Hong WK. Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial. Journal of Cancer Education 10: 88-90, 1995.

• Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK.  Suppression of retinoic acid receptor ß in premalignant oral lesions and its up-regulation by isotretinoin. The New England Journal of Medicine 332: 1405-1410, 1995.

• Lee JS, Yoon A, Kalapurakal SK, Ro JY, Lee JJ, Tu N, Hittelman WN, Hong WK.  Expression of p53 oncoprotein in non-small cell lung cancer: a favorable prognostic factor. Journal of Clinical Oncology 8: 1893-1903,1995.

• Buzaid AC, Tinoco LA, Jendiroba D, Tu ZN, Lee JJ, Legha SS, Ross MI, Balch CM, Benjamin RS.  Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. Journal of Clinical Oncology 13:2361-2368, 1995.

• Sinicrope FA, Hart J, Michelassi F, Lee JJ. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clinical Cancer Research 1: 1103-1110, 1995.

• Xu X-C, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Anti-Retinoic Acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor ß expression. Cancer Research 55: 5507-5511, 1995.

• Walsh GL, O’Connor M, Willis KM, Milas M, Wong R, Nesbitt JC, Putnam JB, Lee JJ, Roth JA.  Is follow-up of lung cancer patients following resection medically indicated and cost effective? Annals of Thoracic Surgery, 60: 1563-1572, 1995.

• Schag CAC, Ganz PA, Wing DS, Sim MS, Lee JJ. Quality of life in adult survivors of lung, colon, and prostate cancer. Quality of Life Research 3: 127-141, 1994.

• Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, Fritzche HA, Hong WK. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. Journal of Clinical Oncology 12:937-945, 1994.

• Lee JJ, Tu ZN. A better confidence interval for Kappa on measuring agreement between two raters with binary outcomes. Journal of Computational and Graphical Statistics 3:301-321, 1994.

• Benner SE, Lippman SM, Wargovich MJ, Lee JJ, Velasco M, Martin JW, Toth BB, Hong WK. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy. International Journal of Cancer 59:457-459, 1994.

• Sinicrope FA, Hart J, Brasitus TA, Michelassi F, Lee JJ, Safa AR. Relationship of P-glycoprotein and Carcinoembryonic Antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer 74: 2908-2917, 1994.

• Trizna Z, Lee JJ, Hsu TC, Benner S, Fritsche HA, Pang A, Hong WK. Protective effects of in vivo 13-cis-Retinoic acid treatment against mutagen-induced genetic damage. Cancer Research Therapy and Control 4:81-85, 1994.

• Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. Comparison of low-dose isotretinoin with ß-carotene to prevent oral carcinogenesis. New England Journal of Medicine 328: 15-20,1993.

• Trizna Z, Hsu TC, Schantz SP, Lee JJ, Hong WK.  Anticlastogenic Effects of 13-cis-Retinoic Acid in vitro. European Journal of Cancer 29A: 137-140, 1993.

• Lee JJ, Li KC, Elashoff RM.  On recensoring for censored paired data. Journal of the American Statistical Association 88: 104-118, 1993.

• Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. Journal of Neurosurgery 79: 210-216, 1993.

• Dimopolous MA, Cabanillas F, Lee JJ, Swan F, Fuller L, Allen PK, Hagemeister FB. Prognostic Role of Serum ß2-Microglobulin in Hodgkin’s Disease. Journal of Clinical Oncology 11: 1108-1111, 1993.

• Trizna Z, Schantz SP, Lee JJ, Spitz MR, Goepfert H, Hsu TC, Hong WK. In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. Cancer Detection and Prevention 17: 575-583, 1993.

• Ganz PA, Schag CAC, Lee JJ, Sim MS. The CARES: A generic measure of health-related quality of life for patients with cancer. Quality of Life Research 1: 19-29, 1992.

• Ganz PA, Schag CAC, Lee JJ, Polinsky ML, Tan SJ. Breast conservation vs. mastectomy: Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69: 1729-1738, 1992.

• Ganz PA, Lee JJ, Sim MS, Polinsky ML, Schag CAC. Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer. Journal of Clinical Epidemiology 45: 473-485, 1992.

• Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. The incidence of second primary tumors in long-term survivors of small cell lung cancer. Journal of Clinical Oncology 10: 1519-1524, 1992.

• Sorensen JA, Doherty FM, Newman MG, Flemmig TF, Lee JJ. Gingival enhancement in fixed prosthodontics, part I: clinical findings. Journal of Prosthetic Dentistry 65: 100-107, 1991.

• Flemmig TF, Sorensen JA, Newman MG, Nachnani S, Calsina G, Doherty FM, Lee JJ. Gingival enhancement in fixed prosthodontics, part II: microbiologic findings. Journal of Prosthetic Dentistry 65: 365-372, 1991.

• Clark GT, Adler RC, Lee JJ. Jaw pain and tenderness levels during and after repeated sustained maximum voluntary protrusion. Pain 45: 17-22, 1991.

• Cochran ST, Barbaric ZL, Lee JJ, Kashfian P. Percutaneous nephrostomy tube placement: an outpatient procedure? Radiology 179: 843-847, 1991.

• Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 67: 3131-3135, 1991.

• Lee JJ. A note on the conditional approach to interval estimation in the calibration problem. Biometrics 47: 1573-1580, 1991.

• Petrocik E, Wassman ER, Lee JJ, Kelly JC.  Second trimester maternal serum pregnancy specific-beta-1 glycoprotein (SP-1) levels in normal and Down Syndrome pregnancies. American Journal of Medical Genetics 37:114-118, 1990.

• Lee JJ, Cochran ST. Rebuttal: evaluation of iopamidol and diatrizoate in excretory urography: a double-blind clinical study. Investigative Radiology 25:1256-1257, 1990.

• Jacobson JJ, Schweitzer S, DePorter DJ, Lee JJ. Antibiotic prophylaxis for dental patients with joint prostheses—a decision analysis. International Journal of Technology Assessment in Health Care 6:569-587, 1990.

• Clark GT, Jow RW, Lee JJ. Jaw pain and stiffness levels after repeat maximum voluntary clenching. Journal of Dental Research 68:69-71,1989.

• Elashoff RM, Lee JJ, Afifi AA.  A note on confidence limits for quartiles with right censored data. Statistics in Medicine 8:1269-1276,1989.

• Gratt BM, Pullinger A, Sickles EA, Lee JJ. Electronic thermography of normal facial structures: a pilot study. Oral Surgery, Oral Medicine, Oral Pathology 68:346-351, 1989.

• Jacobson JJ, Schweitzer S, DePorter DJ, Lee JJ. Chemoprophylaxis of dental patients with prosthetic joints: a simulation model. Journal of Dental Education 52: 599-604, 1988.

• Cochran ST, Ballard JW, Katzberg RW, Barbaric ZL, Spataro R, Iwamoto K, Lee JJ. Evaluation of iopamidol and diatrizoate in excretory urology: a double blind clinical study. American Journal of Radiology 151: 523-527, 1988.

• Afifi AA, Elashoff RM, Lee J J. Simultaneous nonparametric confidence intervals for survival probabilities from censored data. Statistics in Medicine 5: 653-662, 1986.

Publications in Press:

• Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu X-C, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM.  Preventing cancer development in oral leukoplakia: Ten years of translational research. Clinical Cancer Research (in press).

• Tang X, Khuri F, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the DAP-kinase CpG island correlates with aggressive biological behavior in stage I non-small cell lung cancer. Journal of the National Cancer Institute (in press).